美国 · SEC FORM 4
HeartBeam, Inc.
BEAT · Nasdaq · CIK 0001779372 · Healthcare · Health Information Services
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
4 同一窗口内观察到的 Form 4 交易行
0 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
最新留档分数
- 75.5
- 75.6
- 75.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +17.1%
- 3M
- -17.0%
- 6M
- -58.3%
- 12M
- -73.3%
波动率与流动性
- 波动率
- 124.4%
- Beta
- —
- 平均每日成交额
- USD 3.6M
估值
- 市值
- USD 27.0M
- P/E
- —
基本面
- 利润率
- —
- ROE
- -807.3%
- 细分行业
- Health Information Services
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-11 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,493,900
- 上期报告
- 2,124,373
- 日均成交量
- 400,912
- 回补天数
- 6.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | Ferrari Richard | 买入 (P) | Common Stock | 57,500 | USD 0.80 | USD 46,000 | SEC 申报 ↗ |
| 2026-04-16 | Vajdic Branislav | 买入 (P) | Common Stock | 31,250 | USD 0.80 | USD 25,000 | SEC 申报 ↗ |
| 2026-04-16 | STROME MARK E | 买入 (P) | Common Stock | 750,000 | USD 0.80 | USD 600,000 | SEC 申报 ↗ |
| 2026-04-16 | Ortigas-Wedekind Marga | 买入 (P) | Common Stock | 25,000 | USD 0.80 | USD 20,000 | SEC 申报 ↗ |
| 2026-04-16 | JAFF MICHAEL R | 买入 (P) | Common Stock | 31,250 | USD 0.80 | USD 25,000 | SEC 申报 ↗ |
| 2026-04-16 | Ferrari Richard | 买入 (P) | Common Stock | 62,500 | USD 0.80 | USD 50,000 | SEC 申报 ↗ |
| 2026-04-16 | Elfrink Willem | 买入 (P) | Common Stock | 187,500 | USD 0.80 | USD 150,000 | SEC 申报 ↗ |
| 2026-04-16 | ENO Robert Paul | 买入 (P) | Common Stock | 12,500 | USD 0.80 | USD 10,000 | SEC 申报 ↗ |
| 2026-04-16 | Cruickshank Tim | 买入 (P) | Common Stock | 31,250 | USD 0.80 | USD 25,000 | SEC 申报 ↗ |
| 2025-02-14 | Ferrari Richard | 买入 (P) | Common Stock | 29,412 | USD 1.70 | USD 50,000 | SEC 申报 ↗ |
| 2025-02-14 | Cruickshank Tim | 买入 (P) | Common Stock | 17,647 | USD 1.70 | USD 30,000 | SEC 申报 ↗ |
| 2021-12-21 | BROUNSTEIN RICHARD D | 买入 (P) | Common Stock | 5,000 | USD 3.37 | USD 16,850 | SEC 申报 ↗ |
| 2021-11-11 | Ortigas-Wedekind Marga | 买入 (P) | Common Stock | 9,000 | USD 5.99 | USD 53,910 | SEC 申报 ↗ |
| 2021-11-11 | BROUNSTEIN RICHARD D | 买入 (P) | Common Stock | 5,000 | USD 5.99 | USD 29,950 | SEC 申报 ↗ |
Form 4 申报证据
19 transaction lines in the latest 365-day window; 84 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Vajdic Branislav | 奖励／授予 (A) | Common Stock | 260,870 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-24 | Persen Kenneth Harry | 奖励／授予 (A) | Common Stock | 105,740 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-24 | Cruickshank Tim | 奖励／授予 (A) | Common Stock | 167,760 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (19 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Vajdic Branislav | 奖励／授予 (A) | Common Stock | 260,870 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-24 | Persen Kenneth Harry | 奖励／授予 (A) | Common Stock | 105,740 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-24 | Cruickshank Tim | 奖励／授予 (A) | Common Stock | 167,760 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Vajdic Branislav | 奖励／授予 (A) | Common Stock | 2,800,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-16 | Ferrari Richard | 买入 (P) | Common Stock | 57,500 | USD 0.80 | USD 46,000 | SEC 申报 ↗ |
| 2026-04-16 | Vajdic Branislav | 买入 (P) | Common Stock | 31,250 | USD 0.80 | USD 25,000 | SEC 申报 ↗ |
| 2026-04-16 | STROME MARK E | 买入 (P) | Common Stock | 750,000 | USD 0.80 | USD 600,000 | SEC 申报 ↗ |
| 2026-04-16 | Ortigas-Wedekind Marga | 买入 (P) | Common Stock | 25,000 | USD 0.80 | USD 20,000 | SEC 申报 ↗ |
| 2026-04-16 | JAFF MICHAEL R | 买入 (P) | Common Stock | 31,250 | USD 0.80 | USD 25,000 | SEC 申报 ↗ |
| 2026-04-16 | Ferrari Richard | 买入 (P) | Common Stock | 62,500 | USD 0.80 | USD 50,000 | SEC 申报 ↗ |
| 2026-04-16 | Elfrink Willem | 买入 (P) | Common Stock | 187,500 | USD 0.80 | USD 150,000 | SEC 申报 ↗ |
| 2026-04-16 | ENO Robert Paul | 买入 (P) | Common Stock | 12,500 | USD 0.80 | USD 10,000 | SEC 申报 ↗ |
| 2026-04-16 | Cruickshank Tim | 买入 (P) | Common Stock | 31,250 | USD 0.80 | USD 25,000 | SEC 申报 ↗ |
| 2026-02-09 | Nelson Kenneth Warwick III | 奖励／授予 (A) | Common Stock | 17,241 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | JAFF MICHAEL R | 奖励／授予 (A) | Common Stock | 20,689 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | Ferrari Richard | 奖励／授予 (A) | Common Stock | 50,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-18 | de Urioste George | 卖出 (S) | Common Stock | 33,185 | USD 2.83 | USD 93,914 | SEC 申报 ↗ |
| 2025-12-17 | STROME MARK E | 卖出 (S) | Common Stock | 250,000 | USD 3.58 | USD 895,000 | SEC 申报 ↗ |
| 2025-12-17 | de Urioste George | 卖出 (S) | Common Stock | 23,961 | USD 3.68 | USD 88,176 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BEAT |
| CIK | 0001779372 |
| 行业 | Healthcare |
| 细分行业 | Health Information Services Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 84 transaction lines from 2021-11-11 to 2026-07-24 14 P purchase lines · 20 S sale lines · 50 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.